Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
Stocks in this Quantisnow insightHealth Care
Historical context for ACET
Across the 3 sessions after earlier ACET headlines, the stock closed higher 0 times and lower 3 times, with a median move of 2.7% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | ACET | SPY |
|---|---|---|---|
| Nov 6, 2025 | Adicet Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates | -1.9% | -1.1% |
| Nov 3, 2025 | Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | -2.7% | +0.2% |
| Oct 28, 2025 | Adicet Bio to Participate in a Fireside Chat at the Guggenheim 2nd Annual Healthcare Innovation Conference | -5.1% | +0.3% |
Keep researching ACET
Quantisnow market dataNASDAQ
ACET
Adicet Bio Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2018
Get push alerts for ACET
Full ACET profile on Quantisnow Follow ACET and get a push notification the moment its next story breaks.